UMB Financial Corp reports results for the quarter ended June 30 - Earnings Summary
UMB Financial Corp reports results for the quarter ended June 30 - Earnings Summary
UMB Financial Corp UMBF.OQ reported quarterly adjusted earnings of $3.56 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $2.82. The mean expectation of thirteen analysts for the quarter was for earnings of $3.13 per share. Wall Street expected results to range from $2.98 to $3.44 per share.
Revenue rose 12.9% to $778.03 million from a year ago; analysts expected $727.62 million.
UMB Financial Corp's reported EPS for the quarter was $3.56.
The company reported quarterly net income of $271.76 million.
UMB Financial Corp shares had fallen by 1.3% this quarter and gained 22.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 3.1% in the last three months.
In the last 30 days, two analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the banks peer group is also "buy"
Wall Street's median 12-month price target for UMB Financial Corp is $161.00, about 10.6% above its last closing price of $143.98
This summary was machine generated from LSEG data July 29 at 12:00 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 3.13 | 3.56 | Beat |
Mar. 31 2026 | 2.80 | 3.35 | Beat |
Dec. 31 2025 | 2.55 | 2.74 | Beat |
Sep. 30 2025 | 2.45 | 2.36 | Missed |
Recent news on UMB Financial
See all newsBrief: UMB Financial Corp - To Redeem All 2.75% Subordinated Notes Due 2031 On Sept 15, 2026 - SEC Filing
U.S. RESEARCH ROUNDUP-Dollar General, Palo Alto, Workday
Lawsuit against Bristol Myers over delayed cancer drug is revived (updated)
Lawsuit against Bristol Myers over delayed cancer drug is revived
UMB Financial Corp reports results for the quarter ended June 30 - Earnings Summary